This cardiac device maker focused on atrial fibrillation saw a notable insider sale following a year of flat share ...

One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.

Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked ...

Fintel reports that on November 24, 2025, Truist Securities initiated coverage of Xencor (NasdaqGM:XNCR) with a Buy ...

Tractor Supply Company (NASDAQ:TSCO) is included among the 15 Best Stocks to Buy for Medium Term. Evercore ISI upgraded ...